Temperature monitoring
Recording conditions during transit. Monitoring produces evidence of what happened. It does not itself hold a product in range, and it does not certify that a product is fit to administer.
Cold-Chain Transport · Statewide California
Cold-Chain Pharmaceutical Transportation Across California
MedMove transports temperature-sensitive pharmaceutical shipments for specialty pharmacies and qualified healthcare organizations throughout California. The pharmacy, manufacturer, or client defines the approved temperature requirements for the product; MedMove executes the approved transportation plan and documents what happened to the shipment along the way.
MedMove is a business-to-business pharmaceutical transportation company. It does not dispense medications, does not accept requests from individual patients, and does not determine whether a product remains clinically suitable after a temperature event.
Division of Responsibility
Who Decides What in a Cold-Chain Engagement
Cold chain is often described as though the transportation provider owns it. It does not. The pharmacy, manufacturer, or client establishes the approved temperature range, the qualified packaging, the acceptable transit duration, and the procedure to follow if conditions move outside those parameters. That is a product and quality function, and it stays where it belongs.
MedMove's responsibility is execution and evidence: collect the shipment as specified, move it under the approved plan, verify who receives it, document the condition at each transfer, and escalate promptly when something departs from plan. Those are the parts a transportation partner can actually be accountable for.
The distinction matters most after an excursion. At that point the client needs a clear, timely account of what occurred so their own people can make the release decision. What they do not need is a courier offering an opinion on whether the product is still good.
Terms That Are Not Interchangeable
Six Distinctions Worth Making Explicit
Most disputes about a temperature-sensitive shipment trace back to two parties using the phrase cold chain to mean different things. These are the distinctions MedMove settles in writing before a lane starts.
Active temperature control
A system that adds or removes heat during transit to hold a setpoint. Distinct from monitoring, and distinct from passive packaging — the three are frequently conflated in courier marketing.
Passive validated packaging
Qualified packaging engineered to hold a range for a stated duration without power. Its protection is time-limited, which is why long-route thermal duration has to be planned, not assumed.
Refrigerated vehicle systems
Vehicle-level cooling. This is a different capability from qualified shipper packaging and should be specified explicitly in an engagement rather than inferred from the phrase cold chain.
Temperature excursion notification
The procedure for telling the client, promptly and on agreed contacts, that a shipment has moved outside approved parameters — so the client can make the decision that follows.
Product acceptance decisions
The judgment about whether a medication remains suitable after an excursion. This sits with the pharmacy, manufacturer, or qualified healthcare organization, and never with the transportation provider.
Execution
What MedMove Carries Out on a Cold-Chain Mission
Every item below is scoped to the engagement rather than promised universally. Monitoring approach, documentation depth, and escalation timing are set during route assessment against what the product and the receiving site actually require.
Reduced handling is the structural advantage. A dedicated mission has fewer transfer points than a network shipment, which means fewer moments where a package sits on a dock, and a shorter list of people to reconstruct if the condition on arrival is questioned.
Client-approved temperature requirements followed as specified
Product-specific and shipment-specific handling procedures
Qualified packaging appropriate to the engagement
Packaging provided or approved by the pharmacy, manufacturer, or client
Passive temperature logging where applicable
Continuous temperature logging where the engagement requires it
Pickup temperature documentation where required
Delivery temperature documentation where required
Package-condition documentation at collection and handoff
Chain-of-custody documentation from pickup through final delivery
Handoff verification and authorized-recipient verification
Defined escalation and excursion notification procedures
Workflows Served
Where Temperature-Sensitive Missions Come From
Specialty Pharmacy Workflows
Temperature-sensitive dispensed product moving to a patient, provider, or facility on a pharmacy-initiated basis.
Infusion Medication Workflows
Product timed to an infusion appointment, where the receiving site needs it inside a window it can stage and administer.
Oncology Medication Workflows
High-value, patient-specific therapy where a temperature event and a treatment date interact badly.
Fertility Medication Workflows
Protocol-driven shipments where a cycle date fixes the delivery window and substitution is not straightforward.
High-Value Pharmaceutical Shipments
Product where replacement cost, authorization complexity, or limited inventory makes an undocumented handoff unacceptable.
Scheduled and Dedicated Missions
Recurring temperature-sensitive lanes and one-off dedicated missions, both planned around thermal duration.
Long-Route Planning
Thermal Duration Is a Route Constraint, Not a Detail
Qualified packaging protects for a stated period. A statewide California route consumes a meaningful share of that period before the vehicle reaches the destination — and more of it if the recipient is unavailable on arrival. Planning a long temperature-sensitive route therefore means working backwards from the duration the packaging supports, not forwards from a convenient departure time.
Contingency is planned in the same pass: what happens if the receiving site is closed, if the authorized recipient is absent, or if the route is disrupted. Those answers are agreed with the client in advance, because the middle of a long drive is the wrong moment to be deciding them. See long-distance pharmaceutical transportation for how those missions are structured, and exception and rescue transport for shipments that have already failed elsewhere.
Scope Limits
What This Service Does Not Cover
Cold chain spans a wide range of capability, and stating the boundary is more useful than implying coverage. MedMove does not hold itself out as providing:
- Frozen transportation at −20°C
- −60°C or −80°C transportation
- Ultra-low-temperature transportation
- Cryogenic transportation or liquid nitrogen
- Dry-ice transportation
- Cell and gene therapy or CAR-T logistics
- Radiopharmaceuticals or nuclear medicine
- Clinical trial material logistics
- Air cargo, airport handling, or TSA Indirect Air Carrier services
- International transportation
If a shipment needs any of the above, raise it during route assessment. MedMove will confirm whether it can accept the mission; otherwise, the client should engage a provider equipped for those requirements.
Further Reading
Cold-Chain Pharmaceutical Transport Across California: Key Operational Considerations
A longer operational treatment of monitoring approaches, failure modes, handoff documentation, and the geographic factors specific to long-haul California routes.
Read the cold-chain operations articleCommon Questions
Cold-Chain Transportation FAQ
- Does MedMove provide cold-chain transportation?
- Yes. MedMove transports temperature-sensitive pharmaceutical shipments across California under the requirements approved for the engagement, using packaging provided or approved by the pharmacy, manufacturer, or client.
- Who defines the approved temperature range for a shipment?
- The pharmacy, manufacturer, or client does. Those parties define the approved transportation requirements for the product, and MedMove follows the approved transportation plan for that engagement. MedMove does not set or substitute product requirements.
- Does temperature monitoring guarantee the product is still usable?
- No. Monitoring records conditions during transport; it does not preserve or certify a product. If a shipment moves outside approved parameters, MedMove notifies the client according to the agreed escalation procedure. Whether the product remains suitable for administration is determined by the pharmacy, manufacturer, or qualified healthcare organization — never by MedMove.
- Is continuous temperature logging used on every shipment?
- No. Monitoring is matched to what the engagement requires. Some shipments move with basic temperature logging, some require continuous logging for the full transit, and some require pickup and delivery temperature documentation only. The approach is established during route assessment rather than applied uniformly.
- Can MedMove handle frozen, ultra-low-temperature, or cryogenic shipments?
- MedMove does not represent itself as providing frozen, ultra-low-temperature, cryogenic, liquid-nitrogen, or dry-ice transportation, and does not hold itself out as a cell and gene therapy, CAR-T, radiopharmaceutical, or clinical-trial logistics provider. Requirements of that kind should be disclosed during route assessment. MedMove will decline the mission if it cannot support the shipment safely and in accordance with the approved requirements.
- What happens on a long route if the thermal duration is tight?
- Thermal duration is part of route planning before the mission is accepted. Drive time, pickup timing, and contingency are assessed against what the approved packaging is expected to hold for. Where the route cannot be supported within the approved requirements, MedMove says so rather than accepting the mission.
Related Services
Start Here
Define the Requirements With Us
Bring the product requirements, the packaging, the lane, and the escalation expectations. MedMove will confirm what it can execute against them before anything is scheduled.
For healthcare organizations only. Do not submit patient information or protected health information through the assessment form.